{"id":43432,"date":"2026-06-04T10:31:54","date_gmt":"2026-06-04T10:31:54","guid":{"rendered":"https:\/\/insider18.com\/?p=43432"},"modified":"2026-06-04T10:47:01","modified_gmt":"2026-06-04T10:47:01","slug":"uae-launches-oral-wegovy-but-experts-say-the-pill-alone-wont-guarantee-long-term-weight-loss","status":"publish","type":"post","link":"https:\/\/insider18.com\/index.php\/2026\/06\/04\/uae-launches-oral-wegovy-but-experts-say-the-pill-alone-wont-guarantee-long-term-weight-loss\/","title":{"rendered":"UAE launches oral Wegovy, but experts say the pill alone won’t guarantee long-term weight loss."},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The conversation around modern weight-management treatments has undergone a remarkable transformation over the past several years. What began as a medical breakthrough for people living with obesity and related metabolic conditions quickly evolved into a global cultural phenomenon. Images of injectable weight-loss medications became commonplace across news reports, celebrity interviews, wellness podcasts, and social media platforms, where dramatic transformation stories often dominated public attention.<\/p>

For many observers, these medications appeared to represent a revolutionary solution to a long-standing health challenge. Weekly injection devices became instantly recognizable symbols of a new era in obesity treatment, generating both excitement and debate. While healthcare professionals focused on the scientific benefits of these therapies for patients struggling with chronic weight-related conditions, public discussions frequently centered on aesthetics, rapid results, and celebrity endorsements.<\/p>

Now, a significant development is reshaping that narrative in the United Arab Emirates. Rather than relying on an injectable format, patients may soon have access to a tablet-based alternative that could change how these treatments are perceived and used. The shift from injections to oral medication marks an important milestone not only for convenience but also for the broader evolution of obesity care.<\/p>

The Emirates Drug Establishment recently approved oral semaglutide, marketed under the Wegovy brand, for chronic weight management in adults. The treatment is designed for individuals living with obesity as well as those who are overweight and have at least one medical condition linked to excess weight. Beyond its role in supporting weight reduction, the medication has also received recognition for its ability to help lower the risk of major cardiovascular events among certain high-risk patient groups.<\/p>

The approval places the UAE in a unique position on the global healthcare landscape. Following the United States, it is only the second nation to authorize and receive supplies of the oral version of the medication. This development highlights the country’s growing commitment to adopting innovative healthcare solutions and ensuring that patients have access to advanced treatment options.<\/p>

The arrival of a daily pill may appear, at first glance, to be a straightforward improvement in convenience. Many people who are hesitant about injections could find an oral alternative more appealing and easier to incorporate into their daily routines. However, healthcare experts caution that the transition from weekly injections to a tablet should not be interpreted as a fundamental change in the nature of obesity treatment itself.<\/p>

Obesity remains a complex, chronic medical condition influenced by a combination of biological, genetic, environmental, behavioral, and psychological factors. While medications can play an important role in managing the disease, they represent only one component of a comprehensive treatment strategy. Specialists emphasize that long-term success depends on addressing the broader causes and consequences of excess weight rather than focusing exclusively on the number displayed on a scale.<\/p>

This distinction has become increasingly important as public awareness of weight-loss medications continues to grow. Social media discussions often portray these treatments as quick solutions capable of delivering dramatic physical transformations with minimal effort. Medical professionals, however, argue that such perceptions oversimplify the realities of obesity management and risk creating unrealistic expectations among patients.<\/p>

The introduction of oral Wegovy therefore raises several important questions. Does a more convenient delivery method improve patient outcomes by increasing adherence to treatment plans? Could a daily tablet encourage more individuals to seek medical help for obesity? Or might it reinforce the misconception that lasting weight management can be achieved through medication alone?<\/p>

Experts say the answers lie in understanding obesity as a chronic disease rather than a cosmetic concern. Like other long-term conditions such as hypertension or diabetes, obesity often requires ongoing management, continuous monitoring, and a personalized treatment approach. Medication may reduce appetite, improve metabolic function, and support weight loss, but sustainable results typically depend on a combination of medical care, nutrition, physical activity, sleep quality, and behavioral change.<\/p>

Cardiovascular health is another critical aspect of the discussion. Excess weight is associated with an increased risk of heart disease, stroke, high blood pressure, and other serious medical conditions. For many physicians, the most significant value of modern obesity medications extends beyond visible weight reduction. Improvements in cardiovascular outcomes may ultimately prove even more important than changes in body weight alone.<\/p>

This perspective reflects a broader shift within medicine. Increasingly, healthcare providers are moving away from evaluating obesity treatments solely according to the amount of weight lost. Instead, greater attention is being paid to improvements in overall health, disease prevention, quality of life, and long-term survival. From this viewpoint, a successful treatment is not simply one that lowers body weight but one that helps patients achieve better physical and metabolic health.<\/p>

Psychological factors also play a major role in weight management. Many individuals living with obesity experience stigma, self-criticism, anxiety, or depression related to their weight. These emotional challenges can influence eating behaviors, motivation, self-esteem, and adherence to treatment plans. As a result, mental health support is increasingly recognized as a valuable component of comprehensive obesity care.<\/p>

Clinical psychologists note that medications can assist in reducing biological drivers of hunger, but they do not automatically address emotional eating patterns, stress-related behaviors, or deeply ingrained lifestyle habits. Sustainable progress often requires patients to develop healthier relationships with food, physical activity, and their own bodies. Without addressing these underlying factors, maintaining weight loss over the long term may prove difficult regardless of the medication used.<\/p>

The growing availability of advanced therapies has also prompted important conversations about accessibility and patient education. As more treatment options enter the market, healthcare providers face the challenge of ensuring that patients understand both the benefits and limitations of these medications. Clear communication is essential to prevent misunderstandings and encourage realistic expectations.<\/p>

Specialists stress that oral semaglutide should be viewed as a tool rather than a cure. While the medication can support significant health improvements when prescribed appropriately, it is not intended to replace healthy eating habits, regular physical activity, or professional medical guidance. Patients who achieve the best outcomes are often those who integrate medication into a broader, structured health plan tailored to their individual needs.<\/p>

The UAE’s decision to approve the oral formulation reflects the country’s proactive approach to addressing obesity and related chronic diseases. As rates of obesity continue to rise globally, healthcare systems are increasingly seeking innovative solutions that can improve patient engagement and outcomes. Offering a tablet option may help expand access to treatment and reduce barriers for individuals who are uncomfortable with injections.<\/p>

Nevertheless, experts emphasize that convenience alone should not define the conversation. The true significance of this development lies in its potential to support long-term health improvements among individuals living with obesity and associated medical conditions. Whether delivered through an injection or a tablet, effective treatment requires a comprehensive understanding of the disease and a commitment to sustained care.<\/p>

As public interest in weight-loss medications continues to grow, healthcare professionals are encouraging a more balanced and informed discussion. The focus, they argue, should move beyond quick fixes and aesthetic goals toward a deeper understanding of obesity as a serious chronic health condition. Medications can be powerful tools, but they work best when combined with evidence-based lifestyle interventions and ongoing medical supervision.<\/p>

The approval of oral Wegovy represents a noteworthy milestone in the evolution of obesity treatment in the UAE. It signals progress in pharmaceutical innovation and provides patients with an additional therapeutic option. At the same time, it serves as a reminder that meaningful and lasting weight management is rarely achieved through a single intervention.<\/p>

Ultimately, the arrival of a daily weight-management pill is not simply a story about convenience. It is part of a much larger conversation about how society understands obesity, how healthcare systems respond to it, and how patients can be supported in achieving healthier lives. As clinicians, cardiologists, and mental health specialists continue to evaluate the impact of this new option, one message remains consistent: sustainable health outcomes depend on a comprehensive approach that addresses the physical, metabolic, and psychological dimensions of weight management.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Why obesity treatment is about more than weight loss<\/h3>

The introduction of a daily oral weight-management medication represents more than a simple change in how treatment is delivered. According to healthcare experts, it reflects a broader response to the growing burden of obesity, diabetes, and related metabolic disorders that continue to affect millions of people across the region.<\/p>

For Dr. Ihsan Almarzooqi, co-founder and managing director of Metabolic, the swift approval of oral Wegovy highlights how urgently health systems are seeking effective solutions to tackle chronic metabolic diseases. He believes the decision is rooted in strong scientific evidence and the increasing prevalence of conditions linked to excess weight.<\/p>

Dr. Almarzooqi points out that countries across the Gulf region face some of the highest rates of obesity, prediabetes, and Type 2 diabetes globally. These health challenges are not merely issues of appearance or lifestyle preference; they are major contributors to serious medical complications, including cardiovascular disease, fatty liver disease, and kidney disorders. As these conditions continue to place pressure on healthcare systems, new treatment options are becoming increasingly important.<\/p>

One of the main advantages of the tablet form is its convenience. Many patients who are uncomfortable with injections may find a daily pill easier to incorporate into their routine. However, Dr. Almarzooqi stresses that the oral version should not be mistaken for a less effective alternative.<\/p>

He explains that both the tablet and injectable forms contain the same active ingredient and are designed to achieve similar therapeutic outcomes. The primary distinction lies in the method of administration. For some individuals, eliminating the need for injections, refrigeration, and travel-related storage concerns can significantly improve their willingness to begin and continue treatment.<\/p>

At the same time, the convenience of a pill comes with specific usage requirements. To ensure proper absorption, the medication must be taken under carefully controlled conditions. Patients are generally required to take the tablet first thing in the morning with water before consuming food or other beverages. Following these instructions is essential because even small deviations can affect how effectively the drug is absorbed by the body.<\/p>

Clinical studies have demonstrated that when used correctly and consistently, the oral formulation can produce substantial weight-loss results comparable to those achieved with injectable therapy. Research has shown average weight reductions approaching 17 percent over the course of roughly one year among participants who remained committed to treatment.<\/p>

Because of its effectiveness, healthcare professionals emphasize the importance of prescribing the medication only to appropriate candidates. The treatment is intended for adults living with obesity or for individuals who are overweight and also have health conditions associated with excess weight, such as Type 2 diabetes, high blood pressure, or increased cardiovascular risk.<\/p>

There are also several groups for whom the medication may not be suitable. Individuals who are pregnant or have certain medical histories, including specific thyroid cancers or pancreatic conditions, require careful evaluation before treatment is considered. Physicians are particularly cautious about requests from people seeking the medication solely for cosmetic purposes.<\/p>

Dr. Almarzooqi notes that some of the most enthusiastic inquiries often come from individuals who are already within a healthy weight range but hope to lose a few kilograms before a special event, vacation, or social occasion. He emphasizes that these situations do not align with the intended medical purpose of the drug.<\/p>

According to him, prescribing powerful weight-management medications to people without a clinical need can expose them to unnecessary risks while providing limited health benefits. The goal of treatment should be to address obesity and weight-related health conditions rather than support short-term aesthetic objectives. Responsible prescribing, he argues, is essential to ensuring patient safety and maintaining the integrity of evidence-based obesity care.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Can the oral pill reduce risk of heart attack and stroke?<\/h3>

While much of the public discussion surrounding weight-loss medications tends to focus on visible changes in appearance, heart specialists are paying attention to a different and arguably more significant benefit: improved cardiovascular health. The recent approval of oral Wegovy in the UAE was not based solely on its ability to help people lose weight. Regulators also recognized its potential to lower the risk of serious cardiovascular complications, including heart attacks and strokes, among individuals considered vulnerable to such conditions.<\/p>

For Dr. Ahmed Sharafeldin, Consultant Interventional Cardiologist at RAK Hospital, this aspect of the medication may prove especially valuable in a region where heart disease remains one of the leading causes of illness and death. He notes that cardiovascular problems often emerge at relatively younger ages across the Gulf compared with many other parts of the world, making preventive strategies increasingly important.<\/p>

According to Dr. Sharafeldin, the medical community is gradually moving beyond the traditional view of weight reduction as primarily an aesthetic goal. Instead, obesity is being recognized as a major health issue with direct consequences for the heart, blood vessels, and overall metabolic function. As a result, effective obesity treatments are now being evaluated not only by how much weight they help patients lose but also by their ability to reduce long-term health risks.<\/p>

He explains that excess body weight affects the cardiovascular system in numerous ways. Increased fat accumulation can contribute to elevated blood pressure, impaired insulin sensitivity, unhealthy cholesterol levels, and chronic inflammation. Together, these factors create an environment that accelerates damage to blood vessels and increases the likelihood of cardiovascular disease.<\/p>

To illustrate the process, Dr. Sharafeldin compares the body’s circulatory network to a city’s transportation infrastructure. Just as overcrowded roads and constant traffic place strain on a city’s ability to function efficiently, carrying excess weight places additional pressure on the heart and blood vessels. Over time, this burden can lead to congestion within the arteries, causing them to narrow and reducing the flow of oxygen-rich blood to vital organs such as the heart and brain.<\/p>

By helping patients achieve meaningful weight reduction and better metabolic control, medications like oral Wegovy may assist in easing that burden. However, Dr. Sharafeldin emphasizes that the treatment should not be viewed as a substitute for healthy lifestyle choices. While the medication can support medical management, it is not designed to replace the fundamental habits that contribute to long-term cardiovascular health.<\/p>

He cautions against the belief that taking a daily weight-loss pill eliminates the need for exercise, balanced nutrition, or other preventive measures. The clinical approval of the medication is based on its use alongside lifestyle modifications, including calorie-conscious eating and regular physical activity. These measures remain essential components of successful treatment.<\/p>

Dr. Sharafeldin further stresses that patients who combine medical therapy with healthy daily habits tend to achieve the most significant and sustainable improvements. Physical activity, smoking cessation, nutritious food choices, and ongoing medical monitoring continue to play critical roles in reducing cardiovascular risk. Medication can enhance these efforts, but it cannot replace them.<\/p>

Ultimately, experts believe the true value of oral Wegovy lies not only in supporting weight loss but also in its potential to improve overall health outcomes. For cardiologists, the greatest achievement is not a lower number on the scale\u2014it is a reduced likelihood of life-threatening cardiovascular events and a better quality of life for patients over the long term.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The mental health side of weight-loss medication<\/h3>

Although scientific studies highlight the effectiveness of modern weight-loss medications, experts argue that long-term success depends on much more than physical changes alone. Sustainable weight management is often shaped by a person’s emotional health, habits, beliefs, and relationship with food. The convenience of taking a daily tablet can make treatment seem straightforward, but the psychological journey behind significant weight loss is frequently far more complex.<\/p>

According to Alina Vasilache, Clinical Psychologist and Medical Director at Potentia Clinics, obesity should never be viewed solely as a physical condition. She stresses that emotional wellbeing plays a central role in both the development and treatment of weight-related challenges. For many individuals, eating behaviors are deeply connected to self-esteem, personal experiences, relationships, stress, and emotional coping mechanisms.<\/p>

Vasilache describes the introduction of oral weight-loss medication as a positive step forward, providing patients with another valuable treatment option. However, she emphasizes that medication alone cannot resolve the emotional and psychological factors that often contribute to weight gain or difficulty maintaining a healthy lifestyle.<\/p>

In her view, obesity treatment is among the most multifaceted areas of clinical care because it requires addressing not only biological factors but also the emotional experiences that influence behavior. Feelings about body image, confidence, personal identity, and social acceptance can all affect how individuals respond to treatment and whether they are able to sustain progress over time.<\/p>

Many patients begin their weight-loss journey feeling optimistic and empowered. Reduced appetite and fewer food cravings can provide a sense of relief, while physical changes may lead to greater self-confidence and improved social interactions. Yet these benefits do not always eliminate deeper emotional struggles.<\/p>

Vasilache notes that some individuals expect weight loss to solve longstanding issues related to self-worth, insecurity, or emotional distress. When those underlying concerns remain after significant weight reduction, the experience can be frustrating and confusing. Patients may find themselves questioning why they do not feel as fulfilled or emotionally transformed as they anticipated.<\/p>

In other cases, new challenges emerge. Some people become increasingly worried about regaining weight after achieving success, creating anxiety around food, exercise, and body image. Others develop a strong reliance on medication and experience fear at the thought of discontinuing treatment in the future. These concerns can place additional emotional pressure on individuals who are already navigating major lifestyle changes.<\/p>

Mental health support becomes particularly important for patients with a history of complex eating-related issues. Vasilache highlights several situations that warrant closer psychological attention, including binge eating disorder, repeated cycles of weight loss and regain, severe body image disturbances, and patterns of emotional eating used to manage stress or difficult feelings.<\/p>

For these individuals, medication may help reduce hunger and support weight loss, but it does not automatically resolve the emotional triggers that influence eating behavior. Without addressing these deeper issues, patients may continue to struggle despite achieving physical results.<\/p>

She explains that if negative self-talk, low self-esteem, or dissatisfaction with appearance remain unaddressed, emotional difficulties can persist long after the weight has been lost. In some cases, the challenges may even intensify. This can happen when food has previously served as a primary coping mechanism for dealing with stress, anxiety, loneliness, or emotional discomfort. Once that coping strategy is reduced or removed, unresolved emotional issues may become more noticeable and difficult to manage.<\/p>

For this reason, Vasilache believes that the most effective approach to obesity treatment combines medical intervention with psychological care. While medications can help address the biological aspects of weight management, therapy and emotional support can help individuals develop healthier coping strategies, improve self-awareness, and build a more positive relationship with food and their bodies.<\/p>

Ultimately, experts emphasize that lasting success is not determined solely by the amount of weight lost. True progress involves improvements in both physical and emotional wellbeing. By treating obesity through a comprehensive approach that includes medical, nutritional, and psychological support, patients are more likely to achieve meaningful and sustainable health outcomes over the long term.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

What to ask before you start taking oral Wegovy<\/h3>

Medical experts caution that weight-loss medications should never be viewed as a standalone solution. According to Dr. Ihsan Almarzooqi, lasting success depends on combining treatment with meaningful lifestyle adjustments and ongoing support. He warns that relying solely on medication without building healthier habits often leads to a cycle of losing and regaining weight.<\/p>

Research from real-world patient experiences suggests that many individuals regain a significant portion of their lost weight after stopping GLP-1 therapies when lifestyle changes have not been established during treatment. Dr. Almarzooqi explains that medications can create an important opportunity for progress, but long-term outcomes are ultimately determined by the habits patients develop while using them. In his view, the medication provides the initial support, while sustainable behavioral changes are what help preserve results over time.<\/p>

For people in the UAE who are considering oral Wegovy and feel both optimistic about its potential benefits and uncertain about its long-term implications, specialists recommend gathering as much information as possible before beginning treatment.<\/p>

Alina Vasilache, Clinical Psychologist and Medical Director at Potentia Clinics, believes the first step should be an open and detailed conversation with a qualified healthcare professional. She encourages patients to seek clarity on several key issues before making a decision. Understanding realistic weight-loss expectations, possible side effects, treatment duration, follow-up plans, and the type of support available throughout the process can help individuals make informed choices.<\/p>

Equally important, she says, is understanding what may happen if treatment is eventually discontinued. Patients should also ask how their progress will be evaluated, who will be involved in monitoring their health, and what lifestyle modifications will be necessary to maximize the benefits of the medication.<\/p>

Vasilache also encourages individuals to reflect honestly on their relationship with food and eating habits. For some people, food serves purposes beyond physical nourishment, acting as a source of comfort, stress relief, or emotional regulation. When eating patterns are heavily influenced by emotions rather than hunger, professional psychological support can play a valuable role alongside medical treatment.<\/p>

She emphasizes that addressing emotional triggers, improving coping skills, and developing a healthier mindset around food can strengthen long-term outcomes and reduce the risk of setbacks. In many cases, understanding the reasons behind eating behaviors is just as important as managing appetite itself.<\/p>

Another recommendation is to broaden the definition of success. While weight loss is often the most visible result, Vasilache believes patients should pay equal attention to other improvements that reflect better overall health and wellbeing. Increased energy, enhanced mobility, improved sleep, better mood, healthier eating choices, and stronger day-to-day functioning can all be meaningful signs that treatment is having a positive impact.<\/p>

Focusing exclusively on the number displayed on a scale may cause people to overlook these important achievements. Sustainable health improvements often occur in many areas of life, not just through changes in body weight.<\/p>

Throughout the process, Vasilache stresses the importance of self-kindness and realistic expectations. Approaching treatment with patience and compassion can help reduce stress and anxiety while encouraging a healthier relationship with personal progress. She acknowledges that modern medications have created valuable new opportunities for people struggling with obesity and weight-related health conditions, offering support that was unavailable to previous generations.<\/p>

At the same time, she reminds patients that these treatments are only one component of a comprehensive approach to health. The most effective strategies combine medical care, nutritional guidance, physical activity, emotional support, and sustainable lifestyle adjustments tailored to individual needs.<\/p>

Ultimately, the objective is not simply to achieve a lower number on the scale. Rather, it is to help individuals reach a weight that supports better health, improved quality of life, and greater overall wellbeing. Experts emphasize that a person’s value should never be defined by body weight alone. True success lies in building a healthier, more balanced life that can be maintained for years to come.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

The UAE has introduced Wegovy in tablet form, offering a new option for weight management. However, healthcare professionals emphasize that lasting results depend on healthy habits and lifestyle changes, not medication alone.<\/p>\n","protected":false},"author":1,"featured_media":43433,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":""},"categories":[9],"tags":[],"post_template":[],"top_category":[],"class_list":["post-43432","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uae","pmpro-has-access"],"acf":[],"_links":{"self":[{"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/posts\/43432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/comments?post=43432"}],"version-history":[{"count":4,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/posts\/43432\/revisions"}],"predecessor-version":[{"id":43439,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/posts\/43432\/revisions\/43439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/media\/43433"}],"wp:attachment":[{"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/media?parent=43432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/categories?post=43432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/tags?post=43432"},{"taxonomy":"post_template","embeddable":true,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/post_template?post=43432"},{"taxonomy":"top_category","embeddable":true,"href":"https:\/\/insider18.com\/index.php\/wp-json\/wp\/v2\/top_category?post=43432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}